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Abstract
Background: Unnecessary or inappropriate use of antimicrobials is associated with the emergence of antimicrobial
resistance, drug toxicity, increased morbidity and health care costs. Antimicrobial use has been reported to be incorrect or
not indicated in 9–64% of inpatients. We studied the quality of antimicrobial therapy and prophylaxis in hospitalized
patients at a tertiary care hospital to plan interventions to improve the quality of antimicrobial prescription.
Methodology/Principal Findings: Experienced infectious diseases (ID) fellows performed audits of antimicrobial use at
regular intervals among all patients—with or without antimicrobials—hospitalized in predefined surgical, medical,
haemato-oncological, or intensive care units. Data were collected from medical and nursing patient charts with a
standardized questionnaire. Appropriateness of antimicrobial use was evaluated using a modified algorithm developed by
Gyssens et al.; the assessment was double-checked by a senior ID specialist. We evaluated 1577 patients of whom 700
(44.4%) had antimicrobials, receiving a total of 1270 prescriptions. 958 (75.4%) prescriptions were for therapy and 312
(24.6%) for prophylaxis. 37.0% of therapeutic and 16.6% of prophylactic prescriptions were found to be inappropriate. Most
frequent characteristics of inappropriate treatments included: No indication (17.5%); incorrect choice of antimicrobials
(7.6%); incorrect application of drugs (9.3%); and divergence from institutional guidelines (8%). Characteristics of
inappropriate prophylaxes were: No indication (9%); incorrect choice of antimicrobials (1%); duration too long or other
inappropriate use (6.7%). Patterns of inappropriate antimicrobial varied widely in the different hospital units; empirical
prescriptions were more frequently incorrect than prescriptions based on available microbiological results.
Conclusions/Significance: Audits of individual patient care provide important data to identify local problems in
antimicrobial prescription practice. In our study, antimicrobial prescriptions without indication, and divergence from
institutional guidelines were frequent errors. Based on these results, we will tailor education, amend institutional guidelines
and further develop the infectious diseases consultation service.
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Introduction
Antimicrobial therapy and prophylaxis in hospitals has been
reported to be incorrect or not indicated in 9 to 64% [1–16] (table
S1). Reasons for inappropriate prescriptions include uncertainty of
differential diagnoses; complex co-morbidities; lack of training,
experience, or confidence of physicians in charge; lack of
knowledge of local epidemiology of antimicrobial resistance; or
wrong interpretation of microbiological results, e.g. treatment of
colonising bacteria. Consequences of excessive or inappropriate
antimicrobial use are increased morbidity, mortality, and health
care costs, because of the emergence or selection of resistant
microorganisms; increased rate of Clostridium difficile infection,
antimicrobial drug toxicity; drug-drug interactions; catheter-
related infections associated with intravenous administration of
antimicrobials; other nosocomial infections; and prolonged
hospitalisation [17–23].
Antimicrobial stewardship programmes aim to reduce and
optimize antimicrobial use in order to prevent the emergence of
resistance or other adverse effects, improve outcome of care, and
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[24]. Methods of such programmes include: Quantitative
monitoring of antimicrobial use in hospitals or hospital units;
qualitative evaluation of antimicrobial treatment and prophylaxis
in individual patients; monitoring of local antimicrobial suscepti-
bility; promotion of institutional guidelines; and education [24–
27].
Qualitative assessment of antimicrobial use is not widely done
because of lack of standardization, methodological challenges, and
demanding use of human resources. However, acceptance of and
motivation for education of prescribers may be encouraged by
using local quality data, including examples of individual patient
care. Thus, surveys of local prescribing practice among physicians
working in different fields of medicine and in different hospital
units may be a source for improving local institutional guidelines
and tailoring interventions to foster rational and responsible
antimicrobial use.
We studied the quality of antimicrobial therapy and prophylaxis
among individual patients hospitalised at a tertiary care university
hospital in Switzerland by repeated prevalence survey in surgical,
medical and haemato-oncology wards, and in surgical and medical
intensive care units (ICUs).
Methods
Hospital setting
The University Hospital Zurich is an 800-bed tertiary care
teaching hospital. It covers all specialties except paediatrics and
orthopaedics. In 2008, there were 32,724 admissions; the average
length of stay was 8.2 days; and the average use of antimicrobial
agents was 79.8 DDD (defined daily doses) per 100 bed-days and
554.67 DDD per 100 admissions.
Antimicrobials are prescribed by physicians in charge, based on
their own decision, or based on recommendations of infectious
diseases (ID) physicians, if an ID consultation was requested. The
ID consultation service is available 24 hours a day, 7 days a week.
Institutional guidelines on antimicrobial use were developed in
1999 in collaboration with representatives of all medical specialties
and microbiologists, based on international evidence-based
guidelines, local resistance data, costs, and availability of
antimicrobial drugs. The guidelines were regularly updated
thereafter, the current version was updated in March 2008. The
guidelines recommend restrictive use of broad-spectrum antibiot-
ics, of antibiotics associated with the emergence of resistance, of
potentially toxic, or of costly antimicrobials. No mechanisms to
control adherence to guidelines have been implemented so far.
Study population
We evaluated all patients hospitalized in surgical, medical,
oncology and haematology wards, as well as in the surgical and
medical ICUs, excluding patients following lung transplantation.
The surgical wards are divided into thoracic, cardiovascular,
trauma, visceral & transplantation, and plastic & reconstructive
surgery. The medical wards are divided into general internal
medicine, oncology, cardiology, gastroenterology & hepatology,
nephrology, haematology, pneumology, endocrinology & diabetes
& clinical nutrition, angiology, and infectious diseases. The ICUs
are divided in medical, neurosurgery, trauma, visceral, thoracic &
transplant surgery, cardiovascular surgery, and burn ICU.
Study design
We performed a repeated prevalence survey, evaluating all
patients, with and without therapeutic or prophylactic antimicro-
bials, who were registered at a unit at 8 a.m. on the day of an
audit. The audits were performed in the surgical wards during 10
weeks between June and August 2008, in the ICUs during 9 weeks
between October and December 2008, and in the medical wards
during 9 weeks between January and March 2009. In these units,
one audit per week was performed and each patient was only
evaluated once. In the haematology and oncology wards, the
audits were performed during 10 weeks between April and June
2009; patients were evaluated repeatedly during their whole
hospitalisation period at intervals of one week because antimicro-
bial use changed when neutropenia developed in the course of
chemotherapy. Data collection and analysis as well as reporting of
data to surveyed hospital units took approximately 14 months of
full-time work of one ID fellow. Additionally, a senior ID specialist
and a statistician supervised the project.
Data collection
The following patients’ variables were recorded: date of audit,
date of birth, sex, date of hospitalisation, ward, co-morbidity
(estimated using the Charlson’s co-morbidity index by adding one
to six points for the presence of defined diagnoses [28]), surgical
procedures, ICU stay during hospitalisation, current immunosup-
pression, and previous consultation by an ID specialist during
hospitalisation.
In patients with current antimicrobials, we recorded all
prescribed antimicrobial agents (ATC group ‘J’ [29], including
antibiotic, antimycobacterial, antifungal, antiviral, and antipara-
sitic agents), dose, route of administration, date of first prescrip-
tion, and whether the drugs were given in prophylactic or
therapeutic purpose.
Prescriptions were classified as ‘empirical’ when the pathogen
was unknown at the time of prescription, as ‘directed’ when the
pathogen was suspected based on provisional microbiological
result (such as Gram stain), and as ‘targeted’ when a pathogen was
identified.
Furthermore, the results of microbiological, radiological and
pathological investigations available at the time of the survey were
reviewed to assess the appropriateness of diagnoses of infectious
diseases leading to the prescriptions of antimicrobials.
All data were collected by patient chart review; ID study
physicians did not have patient contact in the context of the audits.
Of note, all records of physicians and nurses, and all findings of
laboratory, radiological, microbiological or other examinations
were available in the electronic patient charts.
Assessment of appropriateness of antibiotic use
The appropriateness of antimicrobial prescriptions was evalu-
ated according to local and international evidence-based guide-
lines, and considering local epidemiology of antimicrobial
resistance, microbiological findings, if available, and co-morbidity.
The appropriateness of each prescription was assessed by two ID
physicians; the first judgement was performed by an experienced
ID fellow (AC, SR and VB, respectively), and was then discussed
with a senior ID specialist (RW, or other ID staff physicians).
We classified the appropriateness of antimicrobial treatment
(AMT) using a standardized algorithm initially reported by
Gyssens et al., and modified by Willemsen and colleagues
[4,30]. This algorithm was chosen as a validated method that
allows to systematically evaluate all aspects of antimicrobial
prescription. In brief, AMT was judged as follows:
(A) Appropriate decisions; all criteria of correct antimicrobial
use are fulfilled.
(B) Inappropriate indication; prescription of antimicrobials
without the presence of an infectious disease, or prescription
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antimicrobial treatment.
(C) Inappropriate choice, including inappropriate spectrum of
the antimicrobial agent (too broad, too narrow, not
effective), or inappropriate toxicity profile.
(D) Inappropriate application; including inappropriate dosage,
timing, route of administration and duration of therapy.
(E) Divergence from guidelines.
(F) Missing, or insufficient data to judge the appropriateness of
antimicrobial use.
Ethics
Approval by the local ethics committee (address: Kantonale
Ethikkommission Zu ¨rich, Sonneggstrasse 12, CH-8091 Zu ¨rich,
Switzerland) was obtained. The ethics committed decided that
patients’ informed consent was not required because this study was
a quality control project.
The heads of the various clinics and their staff physicians were
prospectively informed about the study, and accepted the
evaluation methods.
Prescribers were immediately contacted personally after review
of patients’ antimicrobial therapy if current prescription appeared
to have imminent negative consequences for a patient in view of
the evaluating ID physicians.
Statistical analyses
All data were entered into an EpiData database, and analysed
with EpiData Analysis V2 (www.epidata.dk).
Results
Patient characteristics
The demographic and clinical characteristics of study partici-
pants are summarised in Table 1. Between June 2008 and March
2009 a total of 1577 patients were included in the study; 543
patients were registered on the surgical wards, 553 on the medical
wards, 187 on the haemato-oncology wards, and 294 on the ICUs.
The mean age was 57.6 years (range: 16–98), 952 (60.4%) were
male. The proportion of immunocompromised patients was
highest with 73.8% in the haemato-oncology wards. Similarly,
patients on the haemato-oncology wards had the highest Charlson
comorbidity score with a mean of 3.68 (range 2–10). Patients on
the ICUs had a mean comorbidity score of 3.27 (range 0–11).
Antimicrobial use and diagnoses
Of the 1577 evaluated patients, 700 (44.4%) had antimicrobials,
and received a total of 1270 prescriptions. Thereof, 958 (75.4%)
prescriptions were for therapy and 312 (24.6%) for prophylaxis.
252 (80.8%) prophylaxes were prescribed due to immunosuppres-
sion, and 60 (19.2%) prophylaxes were prescribed for surgical or
other interventional procedures. 409 patients received one, 172
Table 1. Patient characteristics.
Characteristics Total Surgical wards Medical wards ICU
Haemato-oncology
wards
No. of evaluated patients (%) 1577 (100) 543 (34.4) 553 (35.1) 294 (18.6) 187 (11.9)
Female 625 (39.6) 248 (45.7) 211 (38.2) 101 (34.4) 65 (34.8)
Male 952 (60.4) 295 (54.3) 342 (61.8) 193 (65.6) 122 (65.2)
Mean age (range) 57.6 (16–98) 56.0 (16–95) 60.4 (16–98) 58.5 (15–94) 55.9 (17–90)
Mean days of hospital stay at time of
evaluation (range)
7.2 (0–180) 5.0 (0–111) 6.8 (0–180) 6.0 (0–102) 7.8 (1–71)
No. of patients with ICU stay during
hospitalisation (%)
508 (32.2) 136 (25.0) 68 (12.3) 294 (100) 10 (5.3)
No. of immunocompromised patients
1 (%) 366 (23.2) 41 (7.6) 150 (27.1) 37 (12.6) 138 (73.8)
Mean Charlson comorbidity index (range) 2.7 (0–11) 1.76 (0–11) 2.99 (0–10) 3.27 (0–11) 3.68 (2–10)
Patient no. with comorbidity index =0 (%) 354 (22.5) 248 (45.7) 66 (11.9) 40 (1.6) 0 (0)
Comorbidity index =1–2 552 (35.0) 150 (27.6) 206 (37.3) 97 (33.0) 99 (52.9)
Comorbidity index =3–4 288 (18.3) 61 (11.2) 138 (25.0) 68 (23.1) 21 (11.2)
Comorbidity index =$5 383 (24.3) 84 (15.5) 143 (25.9) 89 (30.3) 67 (35.8)
Patients on antimicrobials (%) 700 (44.4) 196 (36.1) 255 (46.1) 142 (48.3) 107 (57.2)
Patients on therapy 568 (36.0) 167(30.8) 208 (37.6) 113 (38.4) 80 (42.8)
Patients on prophylaxis 228 (14.5) 33 (6.1) 88 (15.9) 38 (12.9) 69 (36.9)
Total no. of prescriptions (%) 1270 (100) 258 (20.3) 460 (36.2) 224 (17.6) 328 (25.8)
Prescriptions for therapy 958 (75.4) 211 (81.8) 354 (77) 179 (79.9) 214 (65.2)
Prescriptions for prophylaxis 312 (24.6) 47 (18.2) 106 (23.0) 45 (20.1) 114 (34.8)
Prescriptions for surgical prophylaxis 60 (19.2) 20 (42.5) 16 (15.1) 24 (53.3) 0 (0)
Prescriptions for prophylaxis in
immunocompromised patients
252 (80.8) 27 (57.5) 90 (84.9) 21 (46.7) 114 (100)
1Immunosupression includes patients with transplantation, splenectomy, immunosuppressive therapy or steroids, agammaglobulinaemia and cellular
immunodeficiency.
doi:10.1371/journal.pone.0014011.t001
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simultaneously. The highest proportion of patients on antimicro-
bial treatment was in the haemato-oncology wards with 57.2%. In
the ICUs the proportion of patients on antimicrobials was 48.3%,
in the medical wards 46.1%, and in the surgical wards 36.1%.
Table 2 lists the most frequently prescribed antimicrobial agents
for therapy and for prophylaxis in the different units. 39.0% of the
antimicrobial agents were given in parenteral form.
In table 3, diagnoses and main indications for therapeutic use
are summarized. The indications for antimicrobial therapy varied
widely between the different units because of differences in
underlying diseases of patients hospitalised in these units. Overall,
the most frequent diagnoses were respiratory tract infections
(n=138, 21.3%), peritonitis (n=43, 6.6%), sepsis (n=42, 6.5%),
and skin/soft tissue infections (n=41, 6.3%). In 72 (11.1%)
patients receiving antimicrobials, no infection was present.
Appropriateness of antimicrobial therapy and
prophylaxis
Table 4 gives an overview of the evaluation of the appropri-
ateness of antimicrobial use. A total of 406 (32%) prescriptions
were judged as inappropriate. Therapies were more frequently
inappropriate than prophylaxes (37.0% versus 16.6%).
In 171 (27.5%) patients on antimicrobials, receiving a total of
279 therapeutic or prophylactic prescriptions, an ID consultation
was performed during hospitalisation, but this consultation was not
always current on the day of audit. Among patients with ID
consultations, the proportion of inappropriate prescriptions was
16.5%, indicating a significantly lower rate than among patients
without ID consultation.
We found 354 (37%) prescriptions of antimicrobial therapy to
be inappropriate accounting for a total of 407 errors (more than
one criterion defining inappropriateness was possible in one
prescription). Categories of inappropriateness included: 168
(17.5%) no indication, 73 (7.6%) incorrect choice, 89 (9.3%)
incorrect application, and 77 (8%) divergence from local
guidelines.
In the various hospital units there were remarkable differences
in the patterns of inappropriate prescribing. In surgical wards the
main problem was lack of indication in 30.3% of prescriptions,
particularly including pre-emptive antibiotic therapy after surgical
interventions. In the medical wards, no indication was found in
11.6% of prescriptions, divergence from guidelines in 11%, and
inappropriate application in 9.9%. Similar patterns of inappro-
priate use were detected in the haemato-oncology ward: no
indication in 14%, and divergence from guidelines in 11.2%. In
the ICUs, no indication was present in 18.4%, incorrect choice
was observed in 7.8%, and incorrect application in 6.7% of
prescriptions.
Table 5 summarizes the appropriateness with regard to
empirical versus directed and versus targeted antimicrobial
prescriptions. Across all wards, empirical prescriptions were
judged more often as inappropriate (42.6%) than directed
(22.7%) or targeted prescriptions (18.5%) (p=0.001).
55.4% of antimicrobials were prescribed within the first three
days of hospitalization, presumably for community-acquired
infections; and 44.6% of antimicrobials were started after the first
three days of hospitalization, presumably to treat nosocomial
infections. Overall the rates of inappropriateness between these
two types of prescriptions were not different (37.2% versus 35.0%
inappropriate, p=0.78). However, in the haemato-oncology
wards, the proportion of inappropriateness was lower for the
prescriptions within 3 versus after 3 days of hospitalization (17.7%
versus 35%, p=0.43).
Incorrect use of prophylaxis was found for 52 (16.6%)
prescriptions: 28 (9%) no indication, 3 (1%) antibiotic chosen
did not cover the antimicrobial spectrum to be expected, and 21
(6.7%) inappropriate application.
Discussion
We found that 44.4% of patients—hospitalised in medical,
haemato-oncological, and surgical wards, and ICUs at a tertiary
care hospital in Switzerland—received antimicrobials at the time
of audits. Among these, we reviewed a total of 1270 antimicrobial
prescriptions—958 (75.4%) for treatment and 312 (24.6%) for
prophylaxis—concluding that 37.0% of the therapeutic and 16.6%
of the prophylactic prescriptions were inappropriate. There were
remarkable differences in the patterns of inappropriate prescribing
in the different hospital units. The most frequent errors in surgical
wards, medical wards, and ICUs were prescriptions without an
indication, whereas divergence from local guidelines was the most
important concern in haemato-oncology units. Empirical pre-
Table 2. Top ten antimicrobial drugs for treatment in different hospital units: No. (%) of prescriptions.
Surgical wards Medical wards ICU Haemato-oncology wards
Total no. (%) 211 (100) Total no. (%) 354 (100) Total no. (%) 179 (100) Total no. (%) 214 (100)
Amoxicillin-clavulanate 85 (40.3) Piperacillin-tazobactam 58 (16.4) Piperacillin-tazobactam 32 (17.9) Piperacillin-tazobactam 25 (11.7)
Ciprofloxacin 32 (15.2) Amoxicillin-clavulanate 38 (10.7) Amoxicillin-clavulanate 31 (17.3) Aciclovir 23 (10.7)
Piperacillin-tazobactam 19 (9.0) Ceftriaxone 24 (6.8) Meropenem 23 (12.8) Meropenem 19 (8.9)
Metronidazole 14 (6.6) Ciprofloxacin 21 (5.9) Vancomycin 23 (12.8) Amoxicillin-clavulanate 15 (7.0)
Rifampicin 6 (2.8) Metronidazole 18 (5.1) Ciprofloxacin 10 (5.6) Ciprofloxacin 13 (6.1)
Trimethoprim-
sulfamethoxazole
5 (2.4) Valaciclovir 15 (4.2) Ceftriaxone 8 (4.5) Voriconazole 13 (6.1)
Ceftriaxone 4 (1.9) Levofloxacin 10 (2.8) Fluconazole 8 (4.5) Caspofungin 12 (5.6)
Clindamycin 4 (1.9) Fluconazole 9 (2.5) Clindamycin 8 (4.5) Metronidazole 10 (4.7)
Cefuroxime 4 (1.9) Clarythromycin 9 (2.5) Moxifloxacin 8 (4.5) Cefepime 9 (4.2)
Fluconazole 3 (1.4) Meropenem 6 (1.7) Metronidazole 6 (3.4) Valaciclovir 9 (4.2)
Other 35 (16.6) Other 146 (41.2) Other 22 (12.3) Other 66 (30.8)
doi:10.1371/journal.pone.0014011.t002
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prescriptions.
The use of antimicrobial agents has widely been assessed in
hospitals or hospital units by measuring quantitative pharmacy
data to calculate the number of defined daily doses (DDD) per
numbers of occupied bed-days [29], or per hospital admissions of
patients. Results have been used for benchmark purposes, but this
methodology has drawbacks [26]: First, DDD and prescribed daily
doses may differ according to the underlying disease. Second, days
of therapy are underestimated in case of dose reduction, e.g.,
because of reduced renal function. Third, the quantitative
measurement does not indicate whether therapy was appropriate.
Finally, patients’ morbidities may be very different between
hospitals or in different hospital units. Thus, in addition to
quantitative data, assessment of antimicrobial therapy and
prophylaxis in individual patients is needed for quality control.
However, such evaluation is difficult to standardise, particularly in
patients with co-morbidities; requires substantial human resources,
time, and expertise; and may cause conflicts between evaluating
and evaluated physicians.
Although methods for qualitative assessments of antimicrobial
use have been described [30–33], they are not widely used.
Therefore, benchmarking and comparison of results, obtained in
different countries, hospitals or hospital units, appear difficult. We
used an algorithm developed and used by Gyssens et al. [30–31],
and modified by Willemsen et al. [4], which systematically
documents the indication for and use of antimicrobials among
patients with and without such agents. Furthermore, we
determined—according to the antibiotic policy of our hospital—
the adherence to our internal guidelines that we had developed in
collaboration with staff of all hospital units and microbiologists.
We assessed the quality of antimicrobial prescribing in
individual patients during their hospitalisation and while on
antimicrobial therapy or prophylaxis. Limitations of this approach
are that assessment did not take place at time of prescription, and
it was based on chart review and not on clinical examination.
However, the electronic chart provided comprehensive informa-
tion on the course of the hospitalisation, all notes of physicians and
nurses, and on-line reports on microbiological and radiological
findings. We immediately contacted prescribers and asked for
further information at time of evaluation if assessment of
antimicrobial prescription was not possible based on patients’
chart, or if current prescription of antimicrobials appeared to have
imminent negative consequences for a patient in view of
evaluating ID physicians. Strengths of our study are that we
collected data on more than 1200 antimicrobial prescriptions that
are representative for medical and surgical specialties at our
hospital, including wards and ICUs with the highest use.
Furthermore, we considered all classes of antimicrobials (i.e.,
antibiotics, antivirals, antifungals, and antiparasitics); we evaluated
therapy and prophylaxis; we evaluated all aspects of prescribing
(indication, choice of drug, including spectrum, dosing, duration,
and route of administration); and we carefully discussed our
decisions between two ID physicians.
A comparison of published results on the appropriateness of
antimicrobial use in hospitalised patients in various countries and
in different hospital units during the last 10 years is summarized in
table S1. Inappropriate antimicrobial use, although difficult to
compare because of different methods of assessment and different
ways of reporting, ranged between 9% and 64%; most studies
showed rates between 30 and 40%. In all studies, data were
collected with structured questionnaires, and appropriateness was
mostly evaluated by ID specialists. Only five reports refer to
published methods for evaluation of antimicrobial use: One report
[4] refers to the algorithm developed by Gyssens et al. [30]–as
described in our methods section; four studies [1,5,9,16] used
Table 3. Main indications for antimicrobial therapy.
Total Surgical wards Medical wards ICU
Oncology,
haematology wards
Total no. of diagnoses (%)
1 648 (100) 167(100) 208 (100) 113 (100) 160 (100)
Respiratory tract infection 138 (21.3) 12 (7.2) 64 (30.7) 31 (27.4) 31 (19.4)
Peritonitis 43 (6.6) 21(12.6) 7 (3.4) 12 (10.6) 3 (1.9)
Sepsis, bacteraemia 42 (6.5) 6 (3.69 9 (4.3) 20 (17.7) 7 (4.4)
Skin, soft tissue infection 41 (6.3) 10 (6.0) 23 (11.1) 2 (1.8) 6 (3.9)
Fever in neutropenia 35 (5.4) 0 (0) 7 (3.4) 0 (0) 28 (18.2)
Infection of unclear origin 34 (5.2) 7 (4.2) 9 (4.3) 6 (5.3) 12 (7.5)
Gastrointestinal tract infection 32 (4.9) 3 (1.5) 18 (8.7) 2 (1.8) 9 (5.8)
Postoperative wound infection 31 (4.8) 25 (15.0) 0 (0) 6 (5.3) 0 (0)
Traumatic wound/open fracture 29 (4.5) 24 (14.4) 0 (0) 5 (4.4) 0 (0)
Pulmonary aspergillosis 25 (3.9) 0 (0) 5 (2.4) 0 (0) 20 (13.0)
Cardiovascular infection 20 (3.1) 0 (0) 13 (6.2) 7 (6.2) 0 (0)
Urinary tract infection 19 (2.9) 0 (0) 15 (7.2) 1 (0.9) 3 (1.9)
Herpes simplex virus 19 (2.9) 0 (0) 0 0 (0) 19 (12.3)
Hepatitis 10 (1.5) 0 (0) 8 (3.8) 1 (0.9) 1 (0.6)
Infections with Candida 7(1.1) 0 (0) 0 (0) 0 (0) 7 (4.4)
Other 51 (7.9) 16 (9.6) 22 (10.6) 5 (4.4) 8 (5.0)
No infection 72 (11.1) 43 (25.7) 8 (3.8) 15 (13.3) 6 (3.8)
1In the surgical and medical wards and ICUs we documented the leading infection whereas in the haemato-oncology wards all infections occurring during the
hospitalisation were documented.
doi:10.1371/journal.pone.0014011.t003
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effectiveness, toxicity, costs, length of treatment, and appropriate-
ness of indication of antimicrobial use. Reported results do not
consequently distinguish therapy and prophylaxis: Six studies
evaluated therapies, nine evaluated therapies and prophylaxes,
and one report did not provide this information. Several studies
limited the number of analysed antimicrobial agents, or assessed
antibiotics only. The prevalence of patients on antimicrobials, if
Table 4. Evaluation of the appropriateness of antimicrobial treatment and prophylaxis.
Total
Surgical
wards
Medical
wards ICU
Haemato-
oncology
wards
Therapy No. of patients with antimicrobial therapy 568 167 208 113 80
No. of prescriptions (%) 958 (100) 211 (100) 354 (100) 179 (100) 214 (100)
Total no. of inappropriate prescriptions 354 (37.0) 104 (49.3) 115 (32.9) 58 (32.4) 77 (36.0)
Inappropriate indication * Total 168 (17.5) 64 (30.3) 41 (11.6) 33 (18.4) 30 (14.0)
No infection 101 (10.6) 57(27.0) 16 (4.5) 21 (11.7) 7 (3.2)
Infection, no antimicrobials needed 67 (7.0) 7 (3.3) 25 (7.1) 12 (6.7) 23 (10.7)
Inappropriate choice * Total 73 (7.6) 23 (10.9) 30 (8.4) 14 (7.8) 6 (2.8)
Spectrum too broad 31 (3.2) 5 (2.3) 19 (5.3) 7 (3.9) 0 (0)
Spectrum too narrow 16 (1.7) 7 (3.3) 2 (0.6) 2 (1.1) 5 (2.3)
Spectrum ineffective 24 (2.5) 11 (5.2) 9 (2.5) 3 (1.6) 1 (0.5)
Inappropriate toxicity profile 2 (0.2) 0 (0) 0 (0) 2 (1.1) 0 (0)
Inappropriate application * Total 89 (9.3) 20 (9.5) 35 (9.9) 12 (6.7) 22 (10.3)
Dosage 31 (3.2) 2 (9.5) 12 (3.4) 7 (3.9) 10 (4.7)
Timing 20 (2.1) 1 (0.5) 14 (4.0) 2 (1.1) 3 (1.4)
Route of administration 9 (0.9) 3 (1.4) 3 (0.8) 1 (0.6) 2 (1.8)
Duration too long 29 (3.0) 14 (6.6) 6 (1.6) 2 (1.1) 7 (3.3)
Divergence from internal guidelines 77 (8.0) 2 (0.9) 39 (11.0) 12 (6.7) 24 (11.2)
Data insufficient for evaluation of appropriateness 23 (2.4) 0 (0) 9 (2.5) 6 (3.4) 8 (3.7)
Prophylaxis No. of patients with antimicrobial prophylaxis 228 33 88 38 69
No. of prescriptions (%) 312 (100) 47 (100) 106 (100) 45 (100) 114 (100)
Total no. of inappropriate prescriptions 52 (16.6) 6 (12.8) 17 (16.0) 16 (35.6) 13 (11.4)
Inappropriate indication * 28 (9.0) 1 (2.1) 10 (9.4) 8 (17.8) 9 (7.9)
Inappropriate spectrum * 3 (1.0) 0 (0) 1 (0.9) 2 (4.4) 0 (0)
Inappropriate application * Total 21 (6.7) 5 (10.6) 6 (5.6) 6 (13.3) 4 (3.5)
Duration too long 16 (5.1) 5 (10.6) 6 (5.6) 5 (11.1) 0 (0)
Dosage/timing 4 (1.3) 0 (0) 0 (0) 1 (2.2) 4 (3.5)
*One prescription can include more than one inappropriate decision.
doi:10.1371/journal.pone.0014011.t004
Table 5. Appropriateness of empiric, directed, and targeted prescriptions.
Therapy Total Surgical wards Medical wards ICU
Hemato-oncology
wards
Total no. of prescriptions 958 211 354 179 214
Empiric prescriptions* 688 (100) 152 (100) 238 (100) 117 (100) 181 (100)
Inappropriate 292 (42.6) 92 (60.5) 92 (38.7) 48 (41.0) 60 (33.2)
Directed prescriptions* 97 (100) 12 (100) 75 (100) 10 (100) n.a.**
Inappropriate 22 (22.7) 2 (16.7) 16 (21.3) 4 (40.0) n.a.**
Targeted prescriptions* 173 (100) 47 (100) 41 (100) 52 (100) 33 (100)
Inappropriate 32 (18.5) 10(21.3) 7(17.1) 9 (17.3) 6 (18.2)
*Prescriptions were classified as ‘empirical’ when the pathogen was unknown at the time of prescription, as ‘directed’ when the pathogen was suspected based on
provisional microbiological result (such as Gram stain), and as ‘targeted’ when a pathogen was identified.
**n.a.=not applicable. In the haemato-oncology wards we did not differentiate between empirical and directed therapy because in neutropenic patients empirical
therapy is rarely adapted to tentative microbiological results.
doi:10.1371/journal.pone.0014011.t005
Antimicrobial Use in Hospitals
PLoS ONE | www.plosone.org 6 November 2010 | Volume 5 | Issue 11 | e14011reported, ranged between 15%—in a medical department [7]—to
60% in medical and surgical ICUs [8]. Quality of antimicrobial
use is reported as proportion of patients with incorrect treatment
in six studies [4–7,10,12]; as proportion of inappropriate
prescriptions in eight studies [1,3,8–9,13–16]; as proportion of
inappropriately treated infections in one study [2]; and as
unnecessary days of treatment in one study [11]. We preferred
to report our results as proportion of inappropriate prescriptions
(and not as proportion of patients) because 41.6% of our patients
had more than one concurrent prescription at the time of
evaluation. In addition, nine studies provide information on
categories of errors, mainly including antimicrobials without
indication; inappropriate choice, and incorrect use [3–5,8–
10,14–15].
Our results have clinical implications at our hospital: We
identified main patterns of inappropriate antimicrobial prescribing
which we will use to tailor education, to amend institutional
guidelines, and to further develop the ID consultation service.
Major causes of antimicrobial misuse were prescriptions without
indication, unnecessary pre-emptive antibiotics after surgery;
extended duration of perioperative antibiotic prophylaxes; overuse
of broad-spectrum antibiotics; dual antibiotic therapy with
overlapping antimicrobial spectrum; missing adaptation of the
dosage according to renal function; and inappropriate prescrip-
tions following insufficient microbiologic, radiologic or other
essential investigations. Furthermore, we found a high rate of non-
adherence to the institutional guidelines, indicating that it is not
sufficient to provide guidelines but rather necessary to promote
their application. However, guidelines at our institution were
developed involving all stakeholders because prescribers should
accept guidelines as professional support for decision-making
rather than perceive them as an externally or administratively
imposed tool for cost containment. Despite continuous availability
of an ID consultation service, in only 27.5% of patients on
antimicrobials who were evaluated in the audits, an ID
consultation had previously been requested.
In conclusion, audits of antimicrobial use – in addition to
feedback from infectious diseases specialists to individual prescrib-
ers as part of the ID consultation service – are feasible, and are
needed to provide detailed and representative data about specific
patterns of inappropriate prescriptions at an institution. Audits of
individual patient care require significant human resources that
may be the limiting factor for achieving a representative sample
size. Assuming binomial distributions, 30 or 44 prescriptions have
to be evaluated to have a 95% or 99% chance to detect at least one
error occurring with a 10% frequency. For errors of 1%
occurrence, approximately 300 or 460 prescriptions, respectively,
are required. In our experience, the Gyssens’ algorithm is a
reliable tool to measure the appropriateness of antibiotic use and
we recommend using this method for further studies for evaluating
antimicrobial use in individual patients. We found few results in
the literature for comparison and benchmark purposes because
there is no widely used structured and validated standard method
for evaluating antimicrobial use in individual patients. Antimicro-
bials are prescribed by physicians with or without training in
infectious diseases, and therefore, characterization of patterns of
inappropriate antimicrobial use is important for planning of
tailored education. It is, in our opinion, not required that all
antimicrobials are prescribed by ID physicians. However, all
prescribers must have appropriate training, particularly including
education on adverse effects of antimicrobials in individual
patients and on negative long-term public health consequences
of antimicrobial resistance.
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